As of 3:59pm ET
| +0.09 / +1.15%|
The 4 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +58.03% increase from the last price of 7.91.
The current consensus among 5 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.